ARCHIVES

Study: Routine CT Not Needed In Detecting DLBCL Remissions

This article is from The Cancer Letter archive.

Vol. 36 No. 5 | May 31, 2013

Download PDF Visit The Full Archive

Related Articles

Bayer’s HER-2/neu Blood Test Cleared By FDA For Marketing.

December 15, 2000

Two Studies Demonstrate Molecule Blocking Cell Damage

August 26, 2011

NIH Panel Calls For More Attention to Cancer Pain

July 26, 2002

House Approves Additional Funds For NIH and FDA.

June 20, 2008

In Brief: Golomb, Weinstein Head ASCO, AACR; Abeloff, Moses Presidents Elect; Sackett Heads AUR

June 1, 1990

Funding Opportunities: ONS Invites Applications For Instrumentation Grants on Fatigue

January 24, 1997